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Resumo
Objetivos: Avaliar as propriedades psicométricas, juntamente 
com a análise de invariância transcultural, do Questionário de 
Apetite e Sintoma para Pacientes com Câncer (Cancer Appetite 
and Symptom Questionnaire, CASQ).
Métodos: Dados de 555 pacientes com câncer do Reino Unido 
foram utilizados para avaliar as propriedades psicométricas 
do CASQ. A validade de construto foi estimada por meio das 
validades fatorial e convergente. Realizou-se análise fatorial 
confirmatória utilizando como índices a razão de qui-quadrado 
pelos graus de liberdade (χ2/gl), o comparative fit index (CFI), 
o goodness of fit index (GFI) e o root mean square error of 
aproximation (RMSEA). A validade convergente foi estimada pela 
variância extraída média (VEM). A confiabilidade foi estimada 
pela confiabilidade composta e consistência interna. A análise de 
invariância fatorial do CASQ foi avaliada por análise multigrupos 
(∆χ2) usando as amostras do Reino Unido e do Brasil.
Resultados: Todos os itens apresentaram adequada sensibilidade 
psicométrica na amostra do Reino Unido. Um item foi removido 
e foram incluídas quatro correlações entre erros, o que resultou 
em ajustamento adequado do modelo à amostra (χ2/df = 2,674, 
CFI = 0,966, GFI = 0,964, RMSEA = 0,055). A confiabilidade do 
CASQ foi adequada e a validade convergente foi baixa. A estrutura 
fatorial do CASQ diferiu entre os países, e uma falta de invariância 
foi observada para os dois países (λ: ∆χ2 = 64,008, p < 0,001; i: 
∆χ2 = 3515,047, p < 0,001; Res: ∆χ2 = 4452,504, p < 0,001). 
Conclusão: O CASQ apresentou adequadas propriedades 
psicométricas na amostra do Reino Unido. A capacidade de 
estimar a falta de apetite e a presença de sintomas foi diferente 
entre pacientes do Reino Unido e do Brasil.
Descritores: Estudo transcultural, câncer, sintoma, apetite.
Abstract
Objective: To evaluate the psychometric properties, along with 
cross-cultural invariance analysis, of the Cancer Appetite and 
Symptom Questionnaire (CASQ).
Method: Data from 555 United Kingdom (UK) cancer patients 
were used to evaluate the psychometric properties of the CASQ. 
Construct validity was assessed through factorial and convergent 
validity. We conducted a confirmatory factor analysis using as 
indices the chi-square ratio by degrees of freedom (χ2/df), the 
comparative fit index (CFI), the goodness of fit index (GFI), 
and the root mean square error of approximation (RMSEA). 
Convergent validity was estimated by the items’ average 
variance extracted (AVE). Reliability was estimated by composite 
reliability and internal consistency. Factorial invariance analysis 
of the CASQ was evaluated by multigroup analysis (∆χ2) using 
the UK and Brazilian samples. 
Results: All items showed adequate psychometric sensitivity in 
the UK sample. One item was removed and four correlations 
were included between errors with an appropriate fit of the model 
(χ2/df = 2.674, CFI = 0.966, GFI = 0.964, RMSEA = 0.055). 
The reliability of the CASQ was adequate and the convergent 
validity was low. The factorial structure of the CASQ differed 
across countries, and a lack of measurement invariance for the 
two countries was observed (λ: ∆χ2 = 64.008, p < 0.001; i: ∆χ2 = 
3515.047, p < 0.001; Res: ∆χ2 = 4452.504, p < 0.001). 
Conclusion: The CASQ showed adequate psychometric 
properties in the UK sample. The ability to estimate loss of 
appetite and the presence of symptoms was different between 
UK and Brazilian patients. 
Keywords: Cross-cultural study, cancer, symptom, appetite.
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Introduction
Addressing the symptoms caused by cancer and 
its treatment is an important priority in the clinical 
management of patients.1-3 In particular, decreased 
appetite has been linked to weight loss and the 
exacerbation of cachexia.4,5 Cachexia, in turn, has a 
significant impact on quality of life and patient survival.6
The measurement of appetite is a challenge for 
clinicians, since there are many aspects involved that 
need to be considered at the time of evaluation. Wilson 
et al.,6 in this context, proposed the Council on Nutrition 
Appetite Questionnaire (CNAQ) which has since been 
developed into the Cancer Appetite and Symptom 
Questionnaire (CASQ).7 The CASQ dimensions cover 
appetite and symptoms such as satiety, taste, eating 
pattern, mood, and disease-related symptoms such as 
nausea and pain. This instrument, which is predictive 
for weight loss, was proposed in the English language, 
and its reliability, content and predictive validity were 
evaluated and documented in a sample of 185 patients 
with cancer in the United Kingdom (UK).7 Subsequently, 
the cross-cultural adaptation of CASQ into Portuguese 
was completed; its content and construct (factorial and 
convergent) validity and its reliability were assessed with 
a sample of 1,140 Brazilian patients with cancer.8
Given that the validity of an instrument depends on the 
sample it is applied to and not on the instrument itself,9,10 
evaluation of the psychometric properties of the CASQ, in 
terms of validity and reliability, is imperative to determine 
the quality of the information obtained and the instrument’s 
ability to capture the construct studied. Thus, the same 
instrument can capture the construct differently when 
applied to samples with different demographic, social, and/
or cultural characteristics. For this reason, the psychometric 
properties of an instrument must be evaluated for each 
sample prior to comparing their results. In addition, when 
using the same instrument in different countries, there is a 
need to perform the steps of cross-cultural adaptation and 
stability evaluation for the instrument. For that purpose, 
transnational studies are required.
Thus, this study was performed to evaluate the 
psychometric properties of the CASQ for patients with 
cancer when applied to a sample of patients from the 
UK, along with invariance analysis when compared to a 
Brazilian sample.
Method
Study design and sample size
This was a cross-sectional study. The minimum 
sample size was established using the recommendations 
by Hair et al.,11 where a minimum of five to ten subjects 
per model parameter (k) should be investigated to 
evaluate the psychometric quality of an instrument. 
Thus, using α = 5%, β = 20%, k = 10, and considering 
that the CASQ has 24 parameters to be estimated, we 
calculated that the sample size should have at least 240 
subjects, which our dataset exceeded. 
Participants
United Kingdom
Participants were patients with cancer attending 
Nottingham University Hospitals NHS Trust oncology or 
palliative care services. The majority of adult patients 
completed the CASQ as part of their routine clinical 
evaluation by a dedicated rehabilitation service (n = 
370)12; the remainder (n = 185) were participants in 
the initial validity testing of the CASQ.7
Brazil
Participants were adult patients (18 years and above) 
who were attending Hospital de Câncer de Barretos – 
Fundação Pio XII, in Barretos, state of São Paulo, with 
a diagnosis of cancer. 
Exclusion criterion
Those undergoing major and intermediate complex 
surgical procedures, showing cognitive impairment, severe 
psychiatric disorders or edema were excluded. These 
exclusion criteria were used in both the UK and Brazil.
Procedures
Participants from the UK self-completed the CASQ 
based on how they had felt over the last day or two. 
In Brazil, the CASQ was completed through interview. 
Weight and height were assessed by the clinical team 
for the UK participants. These measurements were self-
reported by the Brazilian participants.
Measurement instrument
The CASQ was originally proposed in the English 
language7 with a one-factor model. The instrument 
consists of 12 items with Likert responses of five points 
and four items that were formulated in the opposite 
direction of the remaining eight. In this study, we used 
the original version of the instrument and the Portuguese 
version developed by our research group.8
Psychometric properties
The psychometric properties of the CASQ were 
estimated for the UK sample by evaluating psychometric 
sensitivity and construct-related validity. These 
properties have been estimated previously for the 
Brazilian sample.8
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Data analysis: psychometric qualities
Sensitivity of items
The psychometric sensitivity of items was evaluated 
through measures of central tendency (mean, median, 
mode), variability (standard deviation), and shape 
distribution (skewness and kurtosis). The sensitivity 
was considered appropriate when absolute values of 
skewness and kurtosis were < 3 and <7, respectively,13 
thus indicating absence of severe deviation from 
normality.
Construct validity
Construct validity was assessed by factorial and 
convergent validity. 
Factorial validity
We used confirmatory factor analysis (CFA) with 
maximum likelihood estimation. As indices for assessing 
the goodness of the model fit to the sample, we used 
the chi-square ratio by degrees of freedom (χ2/df), the 
comparative fit index (CFI), the goodness of fit index 
(GFI), and the root mean square error of approximation 
(RMSEA).11,13 The fit model was considered appropriate 
when χ2/df ≤ 2.0, CFI and GFI ≥ 0.9, and RMSEA ≤ 
0.08.11,13 
The items that showed factorial weights (λ) < 0.30 
were removed. Modification indices, calculated by 
Lagrange multipliers (LM), were used to further improve 
the model fit. Correlations between errors of the items 
were entered when LM > 11.13 
Comparison between the original model and the 
model refined using the above stated criteria (λ and LM) 
was performed using information theory indices (Akanke 
information criterion [AIC], Bayesian information 
criterion [BIC], and Browne-Cudeck criterion [BCC]). 
The best model was the one that showed the lowest 
values on one or more of these indices.13
Convergent validity
Convergent validity occurs when the items that 
are reflections of a factor are heavily saturated on this 
factor. It can be estimated by using the items’ average 
variance extracted (AVE) by their respective factors.14 
Convergent validity was considered adequate when AVE 
≥ 0.50.14
Reliability
The reliability of the CASQ was assessed by 
composite reliability (CR) and internal consistency. CR 
was estimated with the Fornell & Larcker14 technique, 
and internal consistency by the standardized Cronbach’s 
alpha coefficient (α), which were considered adequate 
when CR and α ≥ 0.70.
Invariance UK vs. Brazil
The invariance of the CASQ model when applied to the 
UK and Brazilian samples was evaluated by multigroup 
analysis using the chi-square difference statistic (∆χ2). 
The following variables were assessed: i) factor weights 
(λ) (metric invariance/weak invariance); ii) factor weights 
(λ) and item intercepts (i) (scalar invariance/strong 
invariance); iii) factor weights (λ), item intercepts (i) and 
residual variances/covariances (residuals invariance/strict 
invariance) (Res).15 The model was considered invariant 
when ∆χ2 p > 0.05. The explained variance by the model, 
i.e., the proportion of item variances on mean items due to 
the latent factor (appetite and symptoms) in the different 
samples was also calculated.
Ethical considerations 
Data collection in Brazil was approved by the human 
research ethics committee of Hospital de Câncer 
de Barretos (protocol 561/2011). The initial CASQ 
validation study was approved by the Derbyshire local 
research ethics committee (protocol 07/H0401/92). 
Only patients who agreed and signed the informed 
consent form participated in the study.
Results 
Data from 1,140 patients in Brazil and 555 patients 
in the UK were included in the analysis. Table 1 shows 
the sample characteristics.
The mean age of participants from the UK and Brazil 
at the time of completion of the CASQ was 70.00 (SD = 
9.70) and 53.95 (SD = 13.25) years, respectively. Mean 
body mass index was 24.45 kg/m2 (SD = 4.83) for UK 
patients and 25.80 kg/m2 (SD = 5.54) for Brazilians 
patients. It can be observed that the samples from the 
two countries have different characteristics.
Table 2 presents the summary of measures obtained 
for the items in the original version of the CASQ for 
patients with cancer in the UK.
None of the items showed severe deviation 
from normality, indicating appropriate psychometric 
sensitivity.
Figure 1 illustrates the path diagram of the CFA 
performed for the original CASQ structure and for the 
refined fit model to the sample of UK patients with 
cancer.
We observed that in the original model, two items 
(6 and 12) had factor weights lower than 0.30. Thus, 
to improve the psychometric qualities of the CASQ 
for the UK sample, we decided to remove item 6 and 
included four correlations between errors (e1-e3; e4-
e8; e7-e8; e10-e11). These decisions were made using 
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modification indices. The decision to keep item 12 (λ 
< 0.30) was guided by its theoretical significance as 
an important manifestation of decreased appetite. This 
item evaluates pain, which is an aspect that should be 
considered when evaluating different clinical conditions 
including appetite in patients with cancer.
We observed a reduced convergent validity (AVE = 
0.34) of models. The reliability was adequate (CR = 
0.84, α = 0.84).
The only structural difference between the CASQ fit 
models to the UK and Brazilian samples is related to 
item 5 (number of meals per day), which remained in 
the UK sample but had to be excluded from the Brazilian 
sample so that the CASQ showed appropriate fit (CFA: 
λ = 0.34-0.70; χ2/df = 8.532, CFI = 0.94, GFI = 0.95, 
RMSEA = 0.08).8 Thus, seeking the establishment of a 
common model between countries, Figure 2 shows the 
fit to the UK sample model without items 5 and 6.
We observed an appropriate fit of the reduced model 
to the data, with that structure being more simple (lowest 
AIC, BIC and BCC). It was further observed that the 
explained variance of this model was identical to that of 
the refined model shown in Figure 1 (refined model), which 
indicates that item 5 did not contribute significantly to the 
appetite and symptom construct in the UK sample.
When evaluating the factorial invariance of the CASQ 
between the UK and Brazilian samples, the model, while 
appropriately fitting the two samples, was not invariant 
(λ: ∆χ2 = 64.008, p < 0.001; i: ∆χ2 = 3515.047, p < 
0.001; Res: ∆χ2 = 4452.504, p < 0.001).This is observed 
by the differences between the explained variances 
(Brazil = 64%; UK = 88%), as also observed in the 
differences between factorial weights of the items in 
Figure 2 and in Spexoto et al.8
To explore whether this finding was attributable 
to cultural differences between the countries or to 
differences between the samples, it was decided to 
also estimate the invariance between palliative and in-
treatment samples from the two countries (Table 3).
The model was appropriately fit to the samples, but did 
not provide transnational invariance. The explained variance 
by the model was higher for the UK for patients in both the 
Table 2 - Summary of measures of component items of the original version  
of the CASQ for patients with cancer in the United Kingdom
CASQ Mean Median Mode SD Skewness Kurtosis
Item 1 2.10 2 2 1.15 -0.04 -0.80
Item 2 3.06 3 4 1.05 -1.14 0.64
Item 3 1.71 2 2 1.15 -0.09 -0.96
Item 4 2.95 3 4 1.13 -0.74 -0.45
Item 5 2.56 3 3 0.83 -1.40 1.97
Item 6 1.40 1 2 1.06 0.33 -0.52
Item 7 1.69 2 2 0.71 -0.45 1.00
Item 8 3.00 4 4 1.24 -1.04 0.02
Item 9 3.19 4 4 1.08 -1.28 0.93
Item 10 2.23 2 2 0.79 -0.24 0.25
Item 11 1.28 1 2 0.93 0.12 -0.80
Item 12 3.17 4 4 1.00 -1.04 0.45
CASQ = Cancer Appetite and Symptom Questionnaire; SD = standard deviation.
Table 1 - Characteristics of Brazilian and UK participants
Brazil United Kingdom
Characteristic n % n %
Gender
Male 441 38.7 334 60.2
Female 699 61.3 221 39.8
Diagnosis
Head and neck 79 6.9 - -
Upper digestive tract 108 9.5 - -
Lower digestive tract 222 19.5 - -
Gynecology 135 11.8 - -
Hematology 5 0.4 - -
Breast cancer 335 29.4 - -
Brain tumor 17 1.5 - -
Orthopedics 27 2.4 - -
Skin 46 4.0 - -
Thorax* 66 5.8 555 100.0
Urology 100 8.8 - -
Treatment
In treatment 1,016 89.0 152 27.4
Palliative care 120 11.0 403 72.6
Body mass index (kg/m2)
< 18.5 (underweight) 78 6.9 49 8.8
18.5├25.0(healthy weight) 468 41.6 270 48.6
25.0├30.0 (overweight) 363 32.3 170 30.6
≥ 30.0 (obese) 215 19.1 62 11.2
* Lung, pleura and mediastinum.
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palliative and the in-treatment subgroups. The explained 
variance by the model was higher for both countries in the 
palliative treatment samples. The model was not invariant 
between countries for palliative treatment samples (λ:∆χ2 
= 28.210, p = 0.001; i: ∆χ2 = 894.851, p < 0.001; Res: 
∆χ2 = 1433.827, p < 0.001) or for in-treatment samples 
(λ: ∆χ2 = 23.254, p = 0.006; i: ∆χ2 = 1348,530, p < 0.001; 
Res: ∆χ2 = 2289,012, p < 0.001).
Discussion
This study complements the evidence presented 
by Halliday et al.7 on the psychometric properties of 
the CASQ and its use as a tool to predict patients 
at high risk of future weight loss in order to target 
dietetic and anticachexia support in UK individuals 
with cancer.
Although the factorial model was not invariant, it 
was suitable for both countries and therefore can be 
considered in the present study samples as a valid 
method of evaluating appetite and symptoms in patients 
with cancer.
In the UK sample responses, to item 6 referring to 
snacking in addition to, or in replacement of, meals 
did not provide sufficient factorial weight to support 
its maintenance to capture the construct and thus it 
was removed from the instrument. This new model 
CFA: = 0.22-0.84; 2/df = 3.911, CFI = 0.923, GFI = 0.938, 
RMSEA = 0.072, AIC = 257.300, BCC = 258.501, BIC = 
365.274, AVE = 0.32, CR = 0.84, α = 0.83.
Complete model
CFA: = 0.28-0.83; 2/df = 2.674, CFI = 0.966, GFI = 0.964, 
RMSEA = 0.055, AIC = 158.950, BCC = 160.102, BIC = 
271.244, AVE = 0.34, CR = 0.84, α = 0.84.
Refined model
Figure 1 - Factorial structure of the original model of the CASQ and of the refined fit model to the sample of United Kingdom patients 
with cancer. AIC = Akanke information criterion; AVE = average variance extracted; BCC = Browne-Cudeck criterion; BIC = Bayesian 
information criterion; CASQ = Cancer Appetite and Symptom Questionnaire; e = items with correlation between errors; CFA = 
confirmatory factor analysis; CFI = comparative fit index; CR = composite reliability; GFI = goodness of fit index; RMSEA = root mean 
square error of approximation.
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Table 3 - CFA of the CASQ applied to the Brazilian and UK samples according to form of treatment
Brazil United Kingdom
CFA Palliative care In treatment Palliative care In treatment
λ 0.10-0.80 0.26-0.71 0.28-0.83 0.24-0.83
χ2/df 1.58 8.50 2.16 1.96
CFI 0.94 0.91 0.97 0.93
GFI 0.92 0.94 0.96 0.91
RMSEA 0.07 0.09 0.05 0.08
σ2 (%) 88 65 92 74
CASQ = Cancer Appetite and Symptom Questionnaire; CFA = confirmatory factor analysis; CFI = comparative fit index; GFI = 
goodness of fit index; RMSEA = root mean square error of approximation.
 Figure 2 - Factorial structure of the CASQ without items 5 and 6 fit to the sample of United Kingdom cancer patients. Confirmatory factor analysis: λ= 0.28 to 0.82; χ2/df = 2.773, comparative fit index = 0.969, goodness of fit index = 0.968, root mean square error of 
approximation = 0.057, Akanke information criterion = 133.965, Browne-Cudeck criterion = 237.621, Bayesian information criterion = 
134.938, average variance extracted = 0.35, composite reliability = 0.83, α = 0.84). e = items with correlation between errors.
was simpler and showed better fit to the sample. This 
finding was replicated in the Brazilian sample, where 
item 6 was also removed due to the low factor weight. 
In order to complete the evaluation of transnational 
invariance, and for the model to be identical across the 
two countries, it was also necessary to remove item 
5 from the model. Because items 5 and 6 refer to the 
frequency of meals and/or snacks during the day, their 
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interpretation may be influenced by the individual’s 
perception of the meaning of these words.
The absence of model invariance across Brazilian and 
UK samples may be attributed to cultural differences 
that certainly influenced the process of building the 
construct held by the participants. It may be noted 
that the explained variance by the model applied to the 
UK sample was significantly higher than that observed 
in the Brazilian sample, suggesting that the appetite 
symptoms assessed presented a clearer theoretical 
value for the UK patients. Furthermore, the explained 
variance was also higher for samples that included 
participants undergoing palliative care. A possible 
explanation for this is related to how the initial content 
validation work to develop the CASQ was conducted, 
i.e., with an expert panel consisting of UK clinicians, 
caregivers and palliative care patients. It should be 
pointed out that the differences between samples 
(Table 1) do not seem to be responsible for the lack of 
invariance; when comparing subsamples (Table 3), the 
same differences held.
Analysis of the results should consider some study 
limitations, such as its cross-sectional design, which 
prevents the establishment of causality, and the 
differences in the characterization of the samples. 
Despite these limitations, this study screened a 
large sample and included individuals with different 
diagnoses, treatments, and clinical conditions. In 
addition, we sought to divide the sample into individuals 
under palliative and curative treatment in an attempt 
to homogenize the characteristics of the samples from 
both countries, so as to minimize the impact that these 
differences could exert on the evidence presented. The 
present study is, to the best of our knowledge , the first 
to evaluate the construct validity of the CASQ.
Given the significant impact that appetite and 
associated symptoms may have on the health status 
of individuals with cancer, findings suggest that the 
studies for different cultural contexts using the CASQ 
extend the knowledge of its psychometric properties. It 
should be noted that knowledge of these properties is 
essential for assessing the validity and reliability of the 
instrument and thus the information about the quality 
of data collected with it.9,10 Further studies with samples 
from different countries may increase the knowledge of 
professionals seeking the safe use of the CASQ directed 
at particular clinical settings.
Conclusion
The psychometric properties of the CASQ are 
sufficient to support its use in UK patients with cancer. 
However, the operationalization of the construct was 
different for the UK and Brazilian samples, being 
higher in the UK. There were also differences between 
patients receiving palliative care compared to those 
receiving anticancer treatment. These findings suggest 
that cultural, demographic and clinical specificities 
can impact on how patients with cancer report their 
appetite and symptoms. It is therefore recommended 
that the metric properties of the CASQ are properly 
evaluated before its use in different contexts and 
clinical settings. 
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